NextCure Inc expected to post a loss of $1.43 a share - Earnings Preview

What happened

NextCure Inc is expected to report results on November 3 for the period ending September 30, 2026. Analysts expect a loss of $1.43 per share and no change in quarterly revenue, with one buy rating.

Confirmed

Global impact / market context

A loss of $1.43 per share means the company is expected to spend more than it earns per share. For a beginner investor, this shows the company is not yet profitable, so its value depends more on future prospects than current earnings.

Analyst inference

The median 12-month price target is $20.00, about 206.5% above the last closing price of $6.53. That gap suggests analysts see large potential upside, which often reflects high expectations and higher risk rather than certainty.

Analyst inference

What to watch

1. Watch whether the reported loss matches the $1.43 per share estimate and whether quarterly revenue shows any change when results are released on November 3. Confirmed
2. Investors could compare actual results with the unchanged analyst estimates, since any surprise in loss or revenue may shift how the single buy rating is viewed. Proposed
3. Watch whether the gap between the $20.00 price target and the $6.53 closing price narrows, which could signal changing analyst expectations about future profitability. Analyst inference

Evidence

• Original source link unavailable